Last reviewed · How we verify
SNS-032 Injection
At a glance
| Generic name | SNS-032 Injection |
|---|---|
| Sponsor | Sunesis Pharmaceuticals |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study of Intravenously Administered SNS-032 in Patients With Advanced B-lymphoid Malignancies (PHASE1)
- Safety Assessment of One-hour Infusions of SNS-032 for the Treatment of Select Advanced Solid Tumors (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |